Additionally, the xenograft tumors with inducible-depletion of RBM4 demonstrated a much slower growth rate than controls (Fig. 3C), indicating that depleted RBM4 significantly suppresses cancer progression in vivo. The gene discussed is RBM4; the disease is cancer.